{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:11:53Z","timestamp":1772201513098,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Gen-Probe, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.urology.2012.11.069","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T08:31:56Z","timestamp":1363854716000},"page":"998-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?"],"prefix":"10.1016","volume":"81","author":[{"given":"Bertrand","family":"Tombal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald L.","family":"Andriole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de la Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Haese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Speakman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Smets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Stoevelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2012.11.069_bib1","first-page":"835","article-title":"Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng\/ml or less","volume":"161","author":"Carvalhal","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib2","first-page":"1961","article-title":"Prostate cancer detection in black and white men with abnormal digital rectal examination and prostate specific antigen less than 4 ng\/ml","volume":"164","author":"Fowler","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ejca.2004.12.029","article-title":"Screening for prostate cancer","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2012.11.069_bib4","first-page":"813","article-title":"Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer","volume":"163","author":"Fowler","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib6","first-page":"1144","article-title":"Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men","volume":"163","author":"Djavan","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib7","first-page":"2435","article-title":"Serial biopsy results in prostate cancer screening study","volume":"167","author":"Roehl","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jnci\/djm119","article-title":"Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era","volume":"99","author":"Welch","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2012.11.069_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11606-007-0248-7","article-title":"Prostate cancer testing following a negative prostate biopsy: over testing the elderly","volume":"22","author":"Hoffman","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.urology.2012.11.069_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.urology.2010.08.063","article-title":"Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer","volume":"77","author":"Resnick","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.11.069_bib11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1464-410X.2011.10584.x","article-title":"A\u00a0comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy","volume":"109","author":"Auprich","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.11.069_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00345-011-0721-0","article-title":"Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3: a systematic analysis of expert opinion","volume":"30","author":"Tombal","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib13","first-page":"1947","article-title":"PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial","volume":"184","author":"Aubin","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib15","first-page":"2119","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.crad.2005.10.002","article-title":"Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer","volume":"61","author":"Raja","year":"2006","journal-title":"Clin Radiol"},{"key":"10.1016\/j.urology.2012.11.069_bib17","first-page":"2091","article-title":"How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature","volume":"174","author":"Autorino","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib18","first-page":"1830","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib19","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2012.11.069_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2012.11.069_bib22","first-page":"1587","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib23","first-page":"1804","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2010.11.044","article-title":"Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance","volume":"59","author":"Ploussard","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2010.10.024","article-title":"Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging","volume":"59","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2012.11.069_bib27","first-page":"126","article-title":"The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study","volume":"185","author":"Andriole","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib28","first-page":"5135","article-title":"Multi-drug resistant E.\u00a0coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies\u2014three cases including one death","volume":"17","author":"Carlson","year":"2010","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2012.11.069_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1464-410X.2010.09362.x","article-title":"Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling","volume":"106","author":"Moussa","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2012.11.069_bib30","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1464-410X.2011.10584.x","article-title":"A\u00a0comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy","volume":"109","author":"Auprich","year":"2012","journal-title":"BJU Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951300037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951300037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:56:47Z","timestamp":1758765407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951300037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S009042951300037X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2012.11.069","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2012.11.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}